Literature DB >> 20680516

Xenon enhances LPS-induced IL-1β expression in microglia via the extracellular signal-regulated kinase 1/2 pathway.

Astrid V Fahlenkamp1, Mark Coburn, Hajo Haase, Markus Kipp, Yu-Mi Ryang, Rolf Rossaint, Cordian Beyer.   

Abstract

The extracellular signal-regulated kinase (ERK) is involved in the cytokine production of immune cells. In this study, we show the influence of xenon on phosphatase activity, ERK 1/2 signalling and cytokine expression in microglia. The murine microglia cell line BV-2 was treated with 50 ng/ml lipopolysaccharide (LPS) and 74% xenon in 21% O(2) and 5% CO(2). Cytokine levels were examined by gene expression analysis, Western blot and enzyme-linked immunosorbent assay. Phosphatase inhibition was assessed with p-nitrophenylphosphate and phosphorylation of ERK 1/2 via Western blot. Xenon significantly enhanced LPS-mediated IL-1β expression. ERK 1/2 phosphorylation was observed after xenon or LPS treatment which was inhibited by the use of the MEK inhibitor U0126. Xenon and LPS in combination superimposed individual effects on ERK 1/2 activation. Xenon decreased cellular phosphatase activity in microglia by 20% and inhibited dephosphorylation of ERK 1/2 up to 1 h. The blocking of ERK 1/2 reduced IL-1β expression in xenon and LPS-treated cells to a level obtained by LPS alone. In conclusion, xenon enhanced LPS-induced IL-1β expression in microglia by activation of ERK 1/2 signalling. Xenon's interference with phosphatases may be a key feature to affect multiple intracellular signalling pathways.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20680516     DOI: 10.1007/s12031-010-9432-z

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  46 in total

1.  Vanadate inhibition of protein tyrosine phosphatases mimics hydrogen peroxide in the activation of the ERK pathway in alveolar macrophages.

Authors:  Martine Torres; Henry Jay Forman
Journal:  Ann N Y Acad Sci       Date:  2002-11       Impact factor: 5.691

2.  An immortalized cell line expresses properties of activated microglial cells.

Authors:  V Bocchini; R Mazzolla; R Barluzzi; E Blasi; P Sick; H Kettenmann
Journal:  J Neurosci Res       Date:  1992-04       Impact factor: 4.164

3.  Xenon and the inflammatory response to cardiopulmonary bypass in the rat.

Authors:  Jeffrey A Clark; Daqing Ma; H Mayumi Homi; Mervyn Maze; Hilary P Grocott
Journal:  J Cardiothorac Vasc Anesth       Date:  2005-08       Impact factor: 2.628

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  The impact of IL-1 modulation on the development of lipopolysaccharide-induced cognitive dysfunction.

Authors:  Niccolò Terrando; António Rei Fidalgo; Marcela Vizcaychipi; Mario Cibelli; Daqing Ma; Claudia Monaco; Marc Feldmann; Mervyn Maze
Journal:  Crit Care       Date:  2010-05-14       Impact factor: 9.097

Review 6.  Post-ischemic brain damage: pathophysiology and role of inflammatory mediators.

Authors:  Diana Amantea; Giuseppe Nappi; Giorgio Bernardi; Giacinto Bagetta; Maria T Corasaniti
Journal:  FEBS J       Date:  2009-01       Impact factor: 5.542

7.  The neuroprotective effects of xenon and helium in an in vitro model of traumatic brain injury.

Authors:  Mark Coburn; Mervyn Maze; Nicholas P Franks
Journal:  Crit Care Med       Date:  2008-02       Impact factor: 7.598

Review 8.  Inflammation in ischemic brain injury: timing is important.

Authors:  Jasna Kriz
Journal:  Crit Rev Neurobiol       Date:  2006

9.  Xenon preconditioning: the role of prosurvival signaling, mitochondrial permeability transition and bioenergetics in rats.

Authors:  Yasushi Mio; Yon Hee Shim; Ebony Richards; Zeljko J Bosnjak; Paul S Pagel; Martin Bienengraeber
Journal:  Anesth Analg       Date:  2009-03       Impact factor: 5.108

10.  Argon: neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury.

Authors:  Philip D Loetscher; Jan Rossaint; Rolf Rossaint; Joachim Weis; Michael Fries; Astrid Fahlenkamp; Yu-Mi Ryang; Oliver Grottke; Mark Coburn
Journal:  Crit Care       Date:  2009-12-17       Impact factor: 9.097

View more
  7 in total

1.  Expression analysis of the early chemokine response 4 h after in vitro traumatic brain injury.

Authors:  Astrid V Fahlenkamp; Mark Coburn; Michael Czaplik; Yu-Mi Ryang; Markus Kipp; Rolf Rossaint; Cordian Beyer
Journal:  Inflamm Res       Date:  2010-11-23       Impact factor: 4.575

Review 2.  [Neuroprotection by noble gases: New developments and insights].

Authors:  A V Fahlenkamp; R Rossaint; M Coburn
Journal:  Anaesthesist       Date:  2015-11       Impact factor: 1.041

Review 3.  Noble gases as cardioprotectants - translatability and mechanism.

Authors:  Kirsten F Smit; Nina C Weber; Markus W Hollmann; Benedikt Preckel
Journal:  Br J Pharmacol       Date:  2015-01-12       Impact factor: 8.739

4.  Sub-anesthetic Xenon Increases Erythropoietin Levels in Humans: A Randomized Controlled Trial.

Authors:  Christian Stoppe; Julia Ney; Martin Brenke; Andreas Goetzenich; Christoph Emontzpohl; Gereon Schälte; Oliver Grottke; Manfred Moeller; Rolf Rossaint; Mark Coburn
Journal:  Sports Med       Date:  2016-11       Impact factor: 11.136

5.  Xenon pretreatment may prevent early memory decline after isoflurane anesthesia and surgery in mice.

Authors:  Marcela P Vizcaychipi; Dafydd G Lloyd; Yanjie Wan; Mark G Palazzo; Mervyn Maze; Daqing Ma
Journal:  PLoS One       Date:  2011-11-03       Impact factor: 3.240

6.  Effects of pulmonary static inflation with 50% xenon on oxygen impairment during cardiopulmonary bypass for stanford type A acute aortic dissection: A pilot study.

Authors:  Mu Jin; Yanwei Yang; Xudong Pan; Jiakai Lu; Zhiquan Zhang; Weiping Cheng
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

7.  Delayed xenon post-conditioning mitigates spinal cord ischemia/reperfusion injury in rabbits by regulating microglial activation and inflammatory factors.

Authors:  Yan-Wei Yang; Yun-Lu Wang; Jia-Kai Lu; Lei Tian; Mu Jin; Wei-Ping Cheng
Journal:  Neural Regen Res       Date:  2018-03       Impact factor: 5.135

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.